FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC

Reviewer group, Members of EANM Cardiovascular, Members of EANM Infection & Inflammation, Members of Committees, SNMMI Cardiovascular, Members of Council, PET Interest Group, Members of ASNC, EANM Committee Coordinator, Writing group

Research output: Contribution to journalReview article

32 Citations (Scopus)

Abstract

Large vessel vasculitis (LVV) is defined as a disease mainly affecting the large arteries, with two major variants, Takayasu arteritis (TA) and giant cell arteritis (GCA). GCA often coexists with polymyalgia rheumatica (PMR) in the same patient, since both belong to the same disease spectrum. FDG-PET/CT is a functional imaging technique which is an established tool in oncology, and has also demonstrated a role in the field of inflammatory diseases. Functional FDG-PET combined with anatomical CT angiography, FDG-PET/CT(A), may be of synergistic value for optimal diagnosis, monitoring of disease activity, and evaluating damage progression in LVV. There are currently no guidelines regarding PET imaging acquisition for LVV and PMR, even though standardization is of the utmost importance in order to facilitate clinical studies and for daily clinical practice. This work constitutes a joint procedural recommendation on FDG-PET/CT(A) imaging in large vessel vasculitis (LVV) and PMR from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine (EANM), the Cardiovascular Council of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), and the PET Interest Group (PIG), and endorsed by the American Society of Nuclear Cardiology (ASNC). The aim of this joint paper is to provide recommendations and statements, based on the available evidence in the literature and consensus of experts in the field, for patient preparation, and FDG-PET/CT(A) acquisition and interpretation for the diagnosis and follow-up of patients with suspected or diagnosed LVV and/or PMR. This position paper aims to set an internationally accepted standard for FDG-PET/CT(A) imaging and reporting of LVV and PMR.

Original languageEnglish (US)
Pages (from-to)1250-1269
Number of pages20
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume45
Issue number7
DOIs
StatePublished - Jul 1 2018

Fingerprint

Polymyalgia Rheumatica
Public Opinion
Molecular Imaging
Nuclear Medicine
Vasculitis
Cardiology
Joints
Giant Cell Arteritis
Cardiovascular Infections
Takayasu Arteritis
Arteries
Guidelines
Inflammation

Keywords

  • FDG-PET/CT(A)
  • Imaging procedure
  • Large vessel vasculitis
  • Polymyalgia rheumatica

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Reviewer group, Members of EANM Cardiovascular, Members of EANM Infection & Inflammation, Members of Committees, SNMMI Cardiovascular, Members of Council, PET Interest Group, Members of ASNC, ... Writing group (2018). FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. European Journal of Nuclear Medicine and Molecular Imaging, 45(7), 1250-1269. https://doi.org/10.1007/s00259-018-3973-8

FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica : joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. / Reviewer group; Members of EANM Cardiovascular; Members of EANM Infection & Inflammation; Members of Committees, SNMMI Cardiovascular; Members of Council, PET Interest Group; Members of ASNC; EANM Committee Coordinator; Writing group.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, No. 7, 01.07.2018, p. 1250-1269.

Research output: Contribution to journalReview article

Reviewer group, Members of EANM Cardiovascular, Members of EANM Infection & Inflammation, Members of Committees, SNMMI Cardiovascular, Members of Council, PET Interest Group, Members of ASNC, EANM Committee Coordinator & Writing group 2018, 'FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC', European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 7, pp. 1250-1269. https://doi.org/10.1007/s00259-018-3973-8
Reviewer group, Members of EANM Cardiovascular, Members of EANM Infection & Inflammation, Members of Committees, SNMMI Cardiovascular, Members of Council, PET Interest Group, Members of ASNC et al. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. European Journal of Nuclear Medicine and Molecular Imaging. 2018 Jul 1;45(7):1250-1269. https://doi.org/10.1007/s00259-018-3973-8
Reviewer group ; Members of EANM Cardiovascular ; Members of EANM Infection & Inflammation ; Members of Committees, SNMMI Cardiovascular ; Members of Council, PET Interest Group ; Members of ASNC ; EANM Committee Coordinator ; Writing group. / FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica : joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. In: European Journal of Nuclear Medicine and Molecular Imaging. 2018 ; Vol. 45, No. 7. pp. 1250-1269.
@article{3f533839ec8a498f8ea55f18daef909d,
title = "FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC",
abstract = "Large vessel vasculitis (LVV) is defined as a disease mainly affecting the large arteries, with two major variants, Takayasu arteritis (TA) and giant cell arteritis (GCA). GCA often coexists with polymyalgia rheumatica (PMR) in the same patient, since both belong to the same disease spectrum. FDG-PET/CT is a functional imaging technique which is an established tool in oncology, and has also demonstrated a role in the field of inflammatory diseases. Functional FDG-PET combined with anatomical CT angiography, FDG-PET/CT(A), may be of synergistic value for optimal diagnosis, monitoring of disease activity, and evaluating damage progression in LVV. There are currently no guidelines regarding PET imaging acquisition for LVV and PMR, even though standardization is of the utmost importance in order to facilitate clinical studies and for daily clinical practice. This work constitutes a joint procedural recommendation on FDG-PET/CT(A) imaging in large vessel vasculitis (LVV) and PMR from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine (EANM), the Cardiovascular Council of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), and the PET Interest Group (PIG), and endorsed by the American Society of Nuclear Cardiology (ASNC). The aim of this joint paper is to provide recommendations and statements, based on the available evidence in the literature and consensus of experts in the field, for patient preparation, and FDG-PET/CT(A) acquisition and interpretation for the diagnosis and follow-up of patients with suspected or diagnosed LVV and/or PMR. This position paper aims to set an internationally accepted standard for FDG-PET/CT(A) imaging and reporting of LVV and PMR.",
keywords = "FDG-PET/CT(A), Imaging procedure, Large vessel vasculitis, Polymyalgia rheumatica",
author = "{Reviewer group} and {Members of EANM Cardiovascular} and {Members of EANM Infection & Inflammation} and {Members of Committees, SNMMI Cardiovascular} and {Members of Council, PET Interest Group} and {Members of ASNC} and {EANM Committee Coordinator} and {Writing group} and Slart, {Riemer H.J.A.} and Slart, {Riemer H.J.A.} and Glaudemans, {Andor W.J.M.} and Panithaya Chareonthaitawee and Giorgio Treglia and Besson, {Florent L.} and Bley, {Thorsten A.} and Daniel Blockmans and Ronald Boellaard and Jan Bucerius and Carril, {Jos{\'e} Manuel} and Wengen Chen and Cid, {Maria C.} and Bhaskar Dagupta and Sharmila Dorbala and Olivier Gheysens and Fabien Hyafil and Shaifali Jain and Thorsten Klink and {van der Laken}, {Conny J.} and Francisco Lome{\~n}a and Michela Massollo and Sergio Prieto-Gonz{\'a}lez and Raashid Luqmani and Anne Roivainen and Carlo Salvarani and Antti Saraste and Michael Schirmer and Verberne, {Hein J.} and Annibale Versari and Voskuyl, {Alexandre E.} and Walter, {Martin A.} and Dario Camellino and Elisabeth Brouwer and Cimmino, {Marco A.} and Aiden Abidov and Denis Agostini and Beanlands, {Rob S.} and Delgado-Bolton, {Roberto C.} and Einstein, {Andrew J.} and Alessia Gimelli and Miller, {Edward J.} and Roberto Sciagr{\`a} and Alberto Signore and Slart, {Riemer H.J.A.} and Giorgio Treglia",
year = "2018",
month = "7",
day = "1",
doi = "10.1007/s00259-018-3973-8",
language = "English (US)",
volume = "45",
pages = "1250--1269",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer Verlag",
number = "7",

}

TY - JOUR

T1 - FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica

T2 - joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC

AU - Reviewer group

AU - Members of EANM Cardiovascular

AU - Members of EANM Infection & Inflammation

AU - Members of Committees, SNMMI Cardiovascular

AU - Members of Council, PET Interest Group

AU - Members of ASNC

AU - EANM Committee Coordinator

AU - Writing group

AU - Slart, Riemer H.J.A.

AU - Slart, Riemer H.J.A.

AU - Glaudemans, Andor W.J.M.

AU - Chareonthaitawee, Panithaya

AU - Treglia, Giorgio

AU - Besson, Florent L.

AU - Bley, Thorsten A.

AU - Blockmans, Daniel

AU - Boellaard, Ronald

AU - Bucerius, Jan

AU - Carril, José Manuel

AU - Chen, Wengen

AU - Cid, Maria C.

AU - Dagupta, Bhaskar

AU - Dorbala, Sharmila

AU - Gheysens, Olivier

AU - Hyafil, Fabien

AU - Jain, Shaifali

AU - Klink, Thorsten

AU - van der Laken, Conny J.

AU - Lomeña, Francisco

AU - Massollo, Michela

AU - Prieto-González, Sergio

AU - Luqmani, Raashid

AU - Roivainen, Anne

AU - Salvarani, Carlo

AU - Saraste, Antti

AU - Schirmer, Michael

AU - Verberne, Hein J.

AU - Versari, Annibale

AU - Voskuyl, Alexandre E.

AU - Walter, Martin A.

AU - Camellino, Dario

AU - Brouwer, Elisabeth

AU - Cimmino, Marco A.

AU - Abidov, Aiden

AU - Agostini, Denis

AU - Beanlands, Rob S.

AU - Delgado-Bolton, Roberto C.

AU - Einstein, Andrew J.

AU - Gimelli, Alessia

AU - Miller, Edward J.

AU - Sciagrà, Roberto

AU - Signore, Alberto

AU - Slart, Riemer H.J.A.

AU - Treglia, Giorgio

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Large vessel vasculitis (LVV) is defined as a disease mainly affecting the large arteries, with two major variants, Takayasu arteritis (TA) and giant cell arteritis (GCA). GCA often coexists with polymyalgia rheumatica (PMR) in the same patient, since both belong to the same disease spectrum. FDG-PET/CT is a functional imaging technique which is an established tool in oncology, and has also demonstrated a role in the field of inflammatory diseases. Functional FDG-PET combined with anatomical CT angiography, FDG-PET/CT(A), may be of synergistic value for optimal diagnosis, monitoring of disease activity, and evaluating damage progression in LVV. There are currently no guidelines regarding PET imaging acquisition for LVV and PMR, even though standardization is of the utmost importance in order to facilitate clinical studies and for daily clinical practice. This work constitutes a joint procedural recommendation on FDG-PET/CT(A) imaging in large vessel vasculitis (LVV) and PMR from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine (EANM), the Cardiovascular Council of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), and the PET Interest Group (PIG), and endorsed by the American Society of Nuclear Cardiology (ASNC). The aim of this joint paper is to provide recommendations and statements, based on the available evidence in the literature and consensus of experts in the field, for patient preparation, and FDG-PET/CT(A) acquisition and interpretation for the diagnosis and follow-up of patients with suspected or diagnosed LVV and/or PMR. This position paper aims to set an internationally accepted standard for FDG-PET/CT(A) imaging and reporting of LVV and PMR.

AB - Large vessel vasculitis (LVV) is defined as a disease mainly affecting the large arteries, with two major variants, Takayasu arteritis (TA) and giant cell arteritis (GCA). GCA often coexists with polymyalgia rheumatica (PMR) in the same patient, since both belong to the same disease spectrum. FDG-PET/CT is a functional imaging technique which is an established tool in oncology, and has also demonstrated a role in the field of inflammatory diseases. Functional FDG-PET combined with anatomical CT angiography, FDG-PET/CT(A), may be of synergistic value for optimal diagnosis, monitoring of disease activity, and evaluating damage progression in LVV. There are currently no guidelines regarding PET imaging acquisition for LVV and PMR, even though standardization is of the utmost importance in order to facilitate clinical studies and for daily clinical practice. This work constitutes a joint procedural recommendation on FDG-PET/CT(A) imaging in large vessel vasculitis (LVV) and PMR from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine (EANM), the Cardiovascular Council of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), and the PET Interest Group (PIG), and endorsed by the American Society of Nuclear Cardiology (ASNC). The aim of this joint paper is to provide recommendations and statements, based on the available evidence in the literature and consensus of experts in the field, for patient preparation, and FDG-PET/CT(A) acquisition and interpretation for the diagnosis and follow-up of patients with suspected or diagnosed LVV and/or PMR. This position paper aims to set an internationally accepted standard for FDG-PET/CT(A) imaging and reporting of LVV and PMR.

KW - FDG-PET/CT(A)

KW - Imaging procedure

KW - Large vessel vasculitis

KW - Polymyalgia rheumatica

UR - http://www.scopus.com/inward/record.url?scp=85044953161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044953161&partnerID=8YFLogxK

U2 - 10.1007/s00259-018-3973-8

DO - 10.1007/s00259-018-3973-8

M3 - Review article

C2 - 29637252

AN - SCOPUS:85044953161

VL - 45

SP - 1250

EP - 1269

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

SN - 1619-7070

IS - 7

ER -